List of Excipients in API topotecan
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing topotecan
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Novartis Pharmaceuticals Corporation | HYCAMTIN | topotecan | 0078-0672 | FERRIC OXIDE RED | |
| Novartis Pharmaceuticals Corporation | HYCAMTIN | topotecan | 0078-0672 | GELATIN | |
| Novartis Pharmaceuticals Corporation | HYCAMTIN | topotecan | 0078-0672 | GLYCERYL MONOSTEARATE | |
| Novartis Pharmaceuticals Corporation | HYCAMTIN | topotecan | 0078-0672 | TITANIUM DIOXIDE | |
| Hospira Inc | TOPOTECAN | topotecan | 0409-0302 | HYDROCHLORIC ACID | |
| Hospira Inc | TOPOTECAN | topotecan | 0409-0302 | SODIUM HYDROXIDE | |
| Hospira Inc | TOPOTECAN | topotecan | 0409-0302 | TARTARIC ACID | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing topotecan
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Accord Healthcare Inc | topotecan | 16729-243 | HYDROCHLORIC ACID |
| Accord Healthcare Inc | topotecan | 16729-243 | SODIUM HYDROXIDE |
| Accord Healthcare Inc | topotecan | 16729-243 | TARTARIC ACID |
| Accord Healthcare Inc | topotecan | 16729-243 | WATER |
| Ingenus Pharmaceuticals LLC | topotecan | 50742-404 | HYDROCHLORIC ACID |
| Ingenus Pharmaceuticals LLC | topotecan | 50742-404 | MANNITOL |
| Ingenus Pharmaceuticals LLC | topotecan | 50742-404 | SODIUM HYDROXIDE |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for topotecan
Excipient focus: FERRIC OXIDE RED
topotecan drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | topotecan | 0078-0672 |
| >Company | >Ingredient | >NDC |
topotecan drug variants not containing FERRIC OXIDE RED
Excipient focus: GELATIN
topotecan drug variants containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | topotecan | 0078-0672 |
| >Company | >Ingredient | >NDC |
topotecan drug variants not containing GELATIN
Excipient focus: GLYCERYL MONOSTEARATE
topotecan drug variants containing GLYCERYL MONOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | topotecan | 0078-0672 |
| >Company | >Ingredient | >NDC |
topotecan drug variants not containing GLYCERYL MONOSTEARATE
Excipient focus: HYDROCHLORIC ACID
topotecan drug variants containing HYDROCHLORIC ACID
topotecan drug variants not containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | topotecan | 0078-0672 |
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
topotecan drug variants containing MANNITOL
topotecan drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | topotecan | 0078-0672 |
| Hospira Inc | topotecan | 0409-0302 |
| Accord Healthcare Inc | topotecan | 16729-243 |
| Mylan Institutional LLC | topotecan | 67457-662 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
topotecan drug variants containing SODIUM HYDROXIDE
topotecan drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | topotecan | 0078-0672 |
| >Company | >Ingredient | >NDC |
Excipient focus: TARTARIC ACID
topotecan drug variants containing TARTARIC ACID
topotecan drug variants not containing TARTARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | topotecan | 0078-0672 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
topotecan drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | topotecan | 0078-0672 |
| >Company | >Ingredient | >NDC |
topotecan drug variants not containing TITANIUM DIOXIDE
Excipient focus: WATER
topotecan drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Hospira Inc | topotecan | 0409-0302 |
| Teva Parenteral Medicines Inc | topotecan | 0703-4714 |
| Accord Healthcare Inc | topotecan | 16729-243 |
| Mylan Institutional LLC | topotecan | 67457-662 |
| >Company | >Ingredient | >NDC |
topotecan drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
